We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$9.15M
Cap. Flow
-$18.1M
Cap. Flow %
-12.5%
Top 10 Hldgs %
26.79%
Holding
704
New
1
Increased
73
Reduced
49
Closed
564

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$269K
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$197K
3
MO icon
Altria Group
MO
+$144K
4
MPT
Medical Properties Trust
MPT
+$127K
5
XOM icon
ExxonMobil
XOM
+$117K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$582K
2
MPC icon
Marathon Petroleum
MPC
+$200K
3
AER icon
AerCap
AER
+$196K
4
XPO icon
XPO
XPO
+$195K
5
CPB icon
Campbell Soup
CPB
+$186K

Sector Composition

Rank Sector Weight
1 Technology 16.31%
2 Healthcare 10.05%
3 Consumer Staples 8.95%
4 Communication Services 7.78%
5 Industrials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MEDP icon
401
Medpace
MEDP
$16.5B
– –
-119
Closed -$10K
MET icon
402
MetLife
MET
$62.1B
– –
-1,947
Closed -$92K
MFC icon
403
Manulife Financial
MFC
$73.5B
– –
-8,344
Closed -$153K
MGA icon
404
Magna International
MGA
$18.8B
– –
-132
Closed -$7K
MKC icon
405
McCormick & Company Non-Voting
MKC
$14.2B
– –
-42
Closed -$3K
MNST icon
406
Monster Beverage
MNST
$88.5B
– –
-480
Closed -$14K
CALY
407
Callaway Golf Company
CALY
$3.14B
– –
-500
Closed -$10K
MOO icon
408
VanEck Agribusiness ETF
MOO
$973M
– –
-825
Closed -$54K
MPC icon
409
Marathon Petroleum
MPC
$83.7B
– –
-3,300
Closed -$200K
MRTN icon
410
Marten Transport
MRTN
$1.22B
– –
-1,133
Closed -$16K
MRVL icon
411
Marvell Technology
MRVL
$196B
– –
-1,268
Closed -$32K
MTCH icon
412
Match Group
MTCH
$8.55B
– –
-215
Closed -$15K
MTN icon
413
Vail Resorts
MTN
$5.3B
– –
-100
Closed -$23K
MTSI icon
414
MACOM Technology Solutions
MTSI
$23.7B
– –
-237
Closed -$5K
MTUM icon
415
iShares MSCI USA Momentum Factor ETF
MTUM
$25.5B
– –
-502
Closed -$60K
MUB icon
416
iShares National Muni Bond ETF
MUB
$45.9B
– –
-350
Closed -$40K
MXL icon
417
MaxLinear
MXL
$6.8B
– –
-2,122
Closed -$47K
NAAS
418
NaaS Technology Inc
NAAS
$59M
– –
-1
Closed -$33K
NBIX icon
419
Neurocrine Biosciences
NBIX
$16.6B
– –
-38
Closed -$3K
NFG icon
420
National Fuel Gas
NFG
$7.65B
– –
-84
Closed -$4K
NFLX icon
421
Netflix
NFLX
$309B
– –
-5,500
Closed -$147K
NGG icon
422
National Grid
NGG
$81.3B
– –
-1,032
Closed -$49K
NGNE icon
423
Neurogene
NGNE
$712M
– –
-113
Closed -$6K
NHI icon
424
National Health Investors
NHI
$3.65B
– –
-309
Closed -$26K
NKE icon
425
Nike
NKE
$61.9B
– –
-1,796
Closed -$169K
15 16
17
18 19

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Truvestments Capital held 704 positions worth $144M, down 6% from $154M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Truvestments Capital withdrew a net $18.1M in Q4 2019, closing 564 positions and reducing 49 holdings. Its most notable exit was Celgene Corp, an estimated $582K position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Truvestments Capital opened a new position in Vanguard FTSE Developed Markets ETF worth $204K.

  • Truvestments Capital's largest Q4 2019 buy was Vanguard FTSE Developed Markets ETF: 4,627 shares worth $204K.
  • Truvestments Capital added most to Bristol-Myers Squibb in Q4 2019, an estimated $269K increase.
  • Truvestments Capital's biggest Q4 2019 reduction was Apple, cutting an estimated $151K.
  • Truvestments Capital fully exited Celgene Corp in Q4 2019, selling an estimated $582K.
  • Truvestments Capital's ten largest holdings make up 27% of its $144M portfolio in Q4 2019.
  • Truvestments Capital opened 1 new position and closed 564 in Q4 2019.
  • Truvestments Capital's portfolio value fell 6% quarter-over-quarter to $144M.

Based on Truvestments Capital's 13F filing for Q4 2019, filed 29 Jan 2020.